Emre Yekedüz (@yekeduz_emre) 's Twitter Profile
Emre Yekedüz

@yekeduz_emre

MD, Genitourinary Medical Oncologist | Faculty @AnkaraUni | Researcher @DanaFarber_GU @Harvard | Translational Oncol | Editorial Board @BMC_series @OncJournal

ID: 2735430730

linkhttps://coi.asco.org/share/6UB-THQV/Emre%20Yekeduz calendar_today06-08-2014 19:37:17

6,6K Tweet

2,2K Followers

973 Following

Emre Yekedüz (@yekeduz_emre) 's Twitter Profile Photo
Emre Yekedüz
@yekeduz_emre

a month ago

In oligomet castration sensitive prostate cancer with bone mets, adding ☢️Ra223 to ⚡️SABR MDT did not improve ❌PFS (11.8 vs 10.5 mo, HR 1.42, P=.24). 🧬HiRi mutations (ATM, BRCA1/2, RB1, TP53) linked to worse outcomes; 🧫TCR diversity predicted better PFS. ❗️Biomarkers matter.

In oligomet castration sensitive prostate cancer with bone mets, adding ☢️Ra223 to ⚡️SABR MDT did not improve ❌PFS (11.8 vs 10.5 mo, HR 1.42, P=.24). 🧬HiRi mutations (ATM, BRCA1/2, RB1, TP53) linked to worse outcomes; 🧫TCR diversity predicted better PFS. ❗️Biomarkers matter.